natgillin/translations-raw huggingface dataset:
As in the paediatric study described above, fasting plasma glucose reduction from baseline was greater in the insulin glargine group than in the NPH group. 
Tako kot v zgoraj opisani pediatrični študiji je bilo tudi v tej študiji znižanje glukoze v plazmi na tešče v primerjavi z izhodiščem večje v skupini, ki je uporabljala insulin glargin, kot v skupini, ki je uporabljala insulin NPH.
- If you have missed a dose of ABASAGLAR or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia). 
- Če ste izpustili odmerek zdravila ABASAGLAR ali če si niste injicirali dovolj insulina, se vam lahko koncentracija krvnega sladkorja preveč zviša (hiperglikemija).
MedDRA system organ classes 
Organski sistemi po MedDRA
Dysgeusia 
Disgevzija
The recovery of hypoglycaemia may be delayed because ABASAGLAR has a long action.' 
Okrevanje po hipoglikemiji je zaradi dolgega delovanja zdravila ABASAGLAR lahko upočasnjeno.
• Do not try to change your dose while injecting. 
• Med injiciranjem ne poskušajte spreminjati velikosti odmerka.
• KwikPen compatible needle (BD [Becton, Dickinson and Company] pen needles recommended). 
• Igla, združljiva s peresnikom KwikPen (priporočamo igle za peresnik proizvajalca BD [Becton,
You should see insulin at the tip of the needle. 
Na konici igle bi morali zagledati insulin.
Do not use it after this time period. 
Ko to časovno obdobje preteče, ga ne uporabite več.
Mild episodes of hypoglycaemia can usually be treated with oral carbohydrates. 
Blage hipoglikemije je običajno mogoče obvladati z uživanjem ogljikovih hidratov.
Solution for injection 5 cartridges of 3 mL. 
raztopina za injiciranje 5 vložkov po 3 ml 10 vložkov po 3 ml
Packs of 5 and 10 cartridges. 
Na voljo so pakiranja po 5 in 10 vložkov.
This leaflet was last revised in Other sources of information 
Navodilo je bilo nazadnje revidirano.
ABASAGLAR comes in a special cartridge to be used only in a Lilly insulin pen. 
Zdravilo ABASAGLAR je na voljo v posebnem vložku, ki je namenjen le uporabi v insulinskih peresnikih Lilly.
What should you do if you experience hypoglycaemia? 
Kaj narediti, če se pojavi hipoglikemija?
Pre-filled pens in use or carried as a spare may be stored for a maximum of 28 days up to 30°C and away from direct heat or direct light. 
Napolnjene peresnike v uporabi ali peresnike, ki jih imate pri sebi za rezervo, lahko shranjujete največ 28 dni pri temperaturi do 30 ° C in zaščitene pred neposredno toploto in svetlobo.
• Insert the needle into your skin. 
Zabodite iglo v kožo.
It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency. 
Uporabite ga le, če je raztopina v njem bistra, brezbarvna, ne vsebuje vidnih trdnih delcev in je vodi podobne konsistence.
____ insulin glargine 
____ Insulin glargin
Medicines that may cause your blood sugar level to rise (hyperglycaemia) include: 
Med zdravili, ki lahko povzročijo zvišanje koncentracije krvnega sladkorja (hiperglikemija), so:
Excipients: zinc oxide, metacresol, glycerol, hydrochloric acid and sodium hydroxide, water for injections 
Pomožne snovi: cinkov oksid, metakrezol, glicerol, klorovodikova kislina in natrijev hidroksid, voda za injekcije
In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. 
Bolnikom z okvaro ledvic se lahko potreba po insulinu zmanjša zaradi zmanjšane presnove insulina.
Pack of 5 
Pakiranje s 5 peresniki
Insulin antibodies 
Insulinska protitelesa
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON for multipack (with blue box) - KwikPen 
PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA večje pakiranje (z modrim okencem)- peresnik KwikPen
Medicines that may cause your blood sugar level to fall (hypoglycaemia) include: 
Med zdravili, ki lahko povzročijo znižanje koncentracije krvnega sladkorja (hipoglikemija) so:
Similar effects on glycohaemoglobin and the incidence of symptomatic hypoglycaemia were observed in both treatment groups, however fasting plasma glucose decreased more from baseline in the insulin glargine group than in the NPH group. 
V obeh terapevtskih skupinah so ugotovili podobne učinke na glikirani hemoglobin in incidenco simptomatskih hipoglikemij, a glukoza v plazmi na tešče se je v primerjavi z izhodiščem v skupini z insulinom glargin zmanjšala bolj kot v skupini z insulinom NPH.V skupini, ki je uporabljala insulin glargin, je bilo tudi manj hudih hipoglikemij.
• Put used needles in a closable, puncture-resistant sharps container. 
• Uporabljene igle odlagajte v zaprt vsebnik za ostre odpadke, ki je odporen proti vbodom.
• The pen will not let you dial more than the number of units left in the pen. 
• Na peresniku ne morete nastaviti več enot, kot vam jih je še ostalo v peresniku.
- If you are not eating enough your blood sugar level may become too low (hypoglycaemia). 
- Če ne jeste dovolj, se lahko koncentracija krvnega sladkorja preveč zniža (hipoglikemija).
ABASAGLAR is a long-acting insulin. 
Zdravilo ABASAGLAR je dolgodelujoč insulin.
In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements. 
Starejša populacija (≥ 65 let) Pri starejših bolnikih lahko napredujoče slabšanje delovanja ledvic povzroči stalno zmanjševanje potrebe po insulinu.
- If you have injected too much ABASAGLAR, your blood sugar level may become too low (hypoglycaemia). 
- Če ste injicirali preveč zdravila ABASAGLAR, se vam lahko koncentracija krvnega sladkorja preveč zniža (hipoglikemija).
Each pen contains 3 mL of solution for injection, equivalent to 300 units. 
En vložek vsebuje 3 ml raztopine za injiciranje, kar ustreza 300 enotam.
Insulin label must always be checked before each injection to avoid medication errors between insulin glargine and other insulins (see section 4.4). 
Da bi se izognili napakam zdravljenja zaradi zamenjave med insulinom glargin in drugimi insulini, je potrebno nalepko insulina vedno preveriti pred vsakim injiciranjem (glejte poglavje 4.4).
Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions, loss of consciousness. 
poslabšane reakcije, depresija, zmedenost, motnje govora (včasih popolna izguba govora), motnje vida, tresenje, paraliza, mravljinčenje (parestezije), omrtvelost in mravljinčenje v predelu ust, omotica, izguba nadzora nad seboj, nezmožnost poskrbeti zase, krči, izguba zavesti.
ABASAGLAR can be used in adolescents and children aged 2 years and above. 
Zdravilo ABASAGLAR se lahko uporablja pri mladostnikih in otrocih, starih 2 leti in več.
Rubber Seal 
Gumijasta zaporka
Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti , ki je naveden na škatli in nalepki peresnika poleg oznake EXP. Rok uporabnosti se izteče na zadnji dan navedenega meseca.
Each mL contains 100 units insulin glargine (equivalent to 3.64 mg). 
1 ml vsebuje 100 enot insulina glargin (kar ustreza 3,64 mg).
Empty pens must never be reused and must be properly discarded. 
Praznih peresnikov nikoli ne smete uporabiti znova, pač pa jih je treba ustrezno zavreči.
Do not use ABASAGLAR KwikPen if you notice particles in it. Only use ABASAGLAR KwikPen if the solution is clear, colourless and water-like. 
Peresnik ABASAGLAR KwikPen uporabite le, če je raztopina bistra, brezbarvna in podobna vodi.
The warning symptoms of hypoglycaemia may be changed, be less pronounced or be absent in certain risk groups. 
nekaterih ogroženih skupinah bolnikov se opozorilni simptomi hipoglikemije lahko spremenijo, postanejo manj izraziti ali jih sploh ni.Med takšne spadajo bolniki:
Your ability to concentrate or react may be reduced if: - you have hypoglycaemia (low blood sugar levels), - you have hyperglycaemia (high blood sugar levels), - you have problems with your sight. 
- imate hipoglikemijo (nizko koncentracijo krvnega sladkorja), - imate hiperglikemijo (visoko koncentracijo krvnega sladkorja), - imate težave z vidom.
Each cartridge contains 3 mL of solution for injection, equivalent to 300 units. 
En peresnik vsebuje 3 ml raztopine za injiciranje, kar ustreza 300 enotam.
Insulin receptor binding 
Vezava na insulinske receptorje
- The active substance is insulin glargine. 
- Učinkovina je insulin glargin.
For information on the treatment of hypoglycaemia, see box at the end of this leaflet. 
Informacije o zdravljenju hiperglikemije najdete v okviru na koncu tega navodila za uporabo.
ABASAGLAR 100 units/mL solution for injection in a pre-filled pen, KwikPen, is a clear and colourless solution. 
ABASAGLAR 100 enot/ml, raztopina za injiciranje v napolnjenem peresniku KwikPen, je bistra in brezbarvna raztopina.
• Pull off the outer needle shield. 
• Odstranite zaščito zunanje igle.
• If your dose is more than 6080 units, you will need to give more than one injection. 
• če je vaš odmerek več kot 60 80 enot, boste morali dati več kot eno injekcijo - V kolikor potrebujete pomoč kako razdeliti vaš odmerek, se posvetujte z vašim zdravnikom.
The pen in use must not be stored in the refrigerator. 
Peresnika, ki ga uporabljate, ne smete shranjevati v hladilniku.
In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests): - If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia). 
V sledečih okoliščinah lahko vodenje vaše sladkorne bolezni zahteva posebno skrb (npr. prilagoditev odmerka insulina, preiskave krvi in urina):
KwikPen 5 pens of 3 mL. 
5 peresnikov po 3 ml.
HYPERGLYCAEMIA (high blood sugar levels) If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin. 
Če je vaš krvni sladkor previsok (hiperglikemija), si morda niste vbrizgali dovolj insulina.
Each mL contains 100 units insulin glargine* (equivalent to 3.64 mg). 
En mililiter vsebuje 100 enot insulina glargin* (kar ustreza 3,64 mg).
General disorders and administration site conditions Injection site reactions include redness, pain, itching, hives, swelling, or inflammation. 
Reakcije na mestu injiciranja so pordelost, bolečine, srbenje, urtikarija, otekanje ali vnetje.
ABASAGLAR must not be mixed with any other insulin or medicinal products or diluted. 
Zdravila ABASAGLAR se ne sme mešati z nobenim drugim insulinom ali drugim zdravilom in se ga ne sme redčiti.
Adherence of the patient to the dose and dietary regimen, correct insulin administration and awareness of hypoglycaemia symptoms are essential to reduce the risk of hypoglycaemia. 
Za zmanjšanje tveganja za hipoglikemijo mora bolnik nujno upoštevati shemo odmerjanja in načrt prehrane, pravilno aplicirati insulin in poznati simptome hipoglikemije.
What should you do if you experience hyperglycaemia? 
Kaj storiti, če se pojavi hiperglikemija?
There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of insulin glargine. 
Koncentracija insulina ali glukoze v serumu se klinično ne razlikujeta pomembno, če je insulin glargin injiciran v trebuh, deltoidni predel ali stegno.
Insulin glargine injected once daily will reach steady state levels in 2-4 days after the first dose. 
Enkrat na dan injicirani insulin glargin doseže koncentracijo v stanju dinamičnega ravnovesja v 2 do 4
The exposure to M1 increases with the administered dose of insulin glargine. 
Glavna spojina v plazmi je presnovek M1. Izpostavljenost presnovku M1 se povečuje z uporabljenim odmerkom insulina glargin.
Light grey with green ring on the end 
- Gumb za odmerjanje: svetlo siv z zelenim obročem na koncu - Oznake:
A crossover study comparing insulin glargine plus lispro insulin to NPH plus regular human insulin (each treatment administered for 16 weeks in random order) in 26 adolescent type 1 diabetic patients aged 12 to 18 years was also performed. 
Opravljena je bila tudi navzkrižna študija za primerjavo insulina glargin skupaj z insulinom lispro ter insulina NPH skupaj z navadnim humanim insulinom (vsako zdravljenje je bilo uporabljano 16 tednov v slučajnem zaporedju).
The adverse reaction reports received from post marketing surveillance included relatively more frequent injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) in children and adolescents (≤ 18 years of age) than in adults. 
Med neželenimi učinki, poročanimi v postmarketinških raziskavah, se pri otrocih in mladostnikih starih (≤ 18 let) v primerjavi z odraslimi bolniki relativno pogosteje pojavljajo reakcije na mestu injiciranja (bolečina na mestu injiciranja, reakcija na mestu injiciranja) in kožne reakcije (srbenje, urtikarija).
In clinical studies, antibodies that cross-react with human insulin and insulin glargine were observed with the same frequency in both NPH-insulin and insulin glargine treatment groups. 
Klinična varnost in učinkovitost V kliničnih raziskavah so protitelesa, ki navzkrižno reagirajo s človeškim insulinom in insulinom glargin, enako pogosto ugotavljali med prejemniki insulina NPH in insulina glargin.
- determine how much ABASAGLAR per day you will need and at what time, - tell you when to check your blood sugar level, and whether you need to carry out urine tests, - tell you when you may need to inject a higher or lower dose of ABASAGLAR. 
- povedal, kdaj merite krvni sladkor in ali morate opravljati teste urina,
PARTICULARS TO APPEAR ON THE OUTER PACKAGING INTERMEDIATE CARTON of a multipack (without blue box) - KwikPen 
VMESNA OVOJNINA (brez modrega okenca) sestavni del večjega pakiranja - peresnik KwikPen
Common ide effects (may affect up to 1 in 10 people) 
Pogosto poročani neželeni učinki (pojavijo se lahko pri največ 1od 10 bolnikov)
HbA1c changes from baseline were similar between treatment groups; however blood glucose values recorded overnight were significantly higher in the insulin glargine/ lispro group than the NPH/regular group, with a mean nadir of 5.4 mM vs. 4.1 mM. 
Toda vrednosti glukoze v krvi čez noč so bile v skupini z insulinom glargin in insulinom lispro značilno večje kot v skupini z insulinom NPH in navadnim insulinom; povprečna najnižja vrednost je bila v prvi skupini 5,4 mM in v drugi 4,1 mM.
Paper Tab 
Papirni pokrovček
In euglycaemic clamp studies in healthy subjects or in patients with type 1 diabetes, the onset of action of subcutaneous insulin glargine was slower than with human NPH insulin, its effect profile was smooth and peakless, and the duration of its effect was prolonged. 
V študijah z evglikemično vklenjenostjo pri zdravih preiskovancih ali bolnikih z diabetesom tipa 1 je bil začetek delovanja subkutano apliciranega insulina glargin počasnejši kot humanega insulina NPH,
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu 
Podrobne informacije o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila, http://www.ema.europa.eu
Detailed information is available on the website of the European Medicines Agency http://www.ema.europa.eu. 
Podrobne informacije so na voljo na spletni strani Evropske agencije za zdravila, http://www.ema.europa.eu.
Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). 
Zaradi zdravljenja z insulinom lahko telo tvori protitelesa proti insulinu (snovi, ki delujejo proti insulinu), vendar je zelo redko zaradi tega treba spremeniti vaš odmerek insulina.
Over the course of this 6-year study, 42% of the insulin glargine group did not experience any hypoglycaemia. 
preiskovancev v skupini z insulinom glargin ni doživelo nobene hipoglikemije.
Empty pens must not be re-filled and must be properly discarded. 
Praznih vložkov ne smete znova polniti, pač pa jih je treba ustrezno zavreči.
The cartridges should only be used in conjunction with a Lilly reusable insulin pen and should not be used with any other reusable pen as the dosing accuracy has not been established with other pens. 
Ne smete jih uporabljati z nobenim drugim injekcijskim peresnikom za večkratno uporabo, saj natančnost odmerjanja za druge injekcijske peresnike ni bila ugotovljena.
In use: 
Ko je v uporabi:
Empty cartridges must not be refilled and must be properly discarded. 
Praznih peresnikov ne smete znova napolniti, pač pa jih je treba ustrezno zavreči.
In patients with proliferative retinopathy, particularly if not treated with photocoagulation, severe hypoglycaemic episodes may result in transient amaurosis. 
Pri bolnikih s proliferativno retinopatijo lahko hude hipoglikemije povzročijo prehodno slepoto, zlasti če retinopatija ni zdravljena s fotokoagulacijo.
- get a new pen and inject the full dose. 
Pritrdite novo iglo in aktivirajte injekcijski peresnik
The pen should be used as recommended in the information provided. 
Peresnik morate uporabljati, kot je priporočeno v priloženih navodilih.
ABASAGLAR 100 units/mL solution for injection in a cartridge is a clear and colourless solution. 
ABASAGLAR 100 enot/ml, raztopina za injiciranje v vložku, je bistra in brezbarvna raztopina.
• Carefully replace the outer needle shield. 
Previdno znova namestite zaščito zunanje igle.
• Pull the pen cap straight off. 
• S hitrim potegom odstranite pokrovček s peresnika.
Store in original package in order to protect from light. 
Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
Look at the cartridge before you use it. Only use it if the solution is clear, colourless and water-like, and has no visible particles in it. Do not shake or mix it before use. 
Uporabite jo le, če je raztopina v njej bistra, brezbarvna, podobna vodi in ne vsebuje vidnih delcev.
A 24-week parallel group study was conducted in 125 children with type 1 diabetes mellitus aged 2 to 6 years, comparing insulin glargine given once daily in the morning to NPH insulin given once or twice daily as basal insulin. 
Opravljena je bila 24-tedenska študija za primerjavo bazalnih insulinov, tj. insulina glargin, ki so ga uporabljali enkrat na dan (zjutraj), in insulina NPH, ki so ga uporabljali enkrat ali dvakrat na dan.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON - KwikPen. 
PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA - peresnik KwikPen.
No significant difference was seen in the progression of diabetic retinopathy when insulin glargine was compared to NPH insulin. 
Ko so primerjali insulin glargin z insulinom NPH, pri razvoju diabetične retinopatije niso opazili pomembnih razlik.
The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if - you are elderly, if you have had diabetes for a long time or if you suffer from a certain type of nervous disease (diabetic autonomic neuropathy), - you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly, - you have almost normal or, at least, greatly improved blood sugar levels, - you have recently changed from an animal insulin to a human insulin such as ABASAGLAR, - you are taking or have taken certain other medicines (see section 2, "Other medicines and 
- ste nedavno (na primer prejšnji dan) doživeli hipoglikemijo ali če se hipoglikemija pojavi počasi, - imate skoraj normalno ali vsaj močno izboljšano koncentracijo krvnega sladkorja, - ste namesto živalskega insulina pred kratkim začeli uporabljati humani insulin, kakršen je zdravilo ABASAGLAR,
Look at the cartridge before you use the pen. 
Vložek si pred uporabo peresnika oglejte.
ABASAGLAR must not be mixed with any other insulin or diluted. 
Zdravila ABASAGLAR se ne sme mešati z nobenim drugim insulinom in se ga ne sme redčiti.
- unaccustomed, increased or prolonged physical activity, - intercurrent illness (e.g. vomiting, diarrhoea), - inadequate food intake, - missed meals, - alcohol consumption, - certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency), - concomitant treatment with certain other medicinal products. 
- določene nekompenzirane endokrine motnje (npr. hipotiroidizem, insuficienca sprednjega režnja hipofize ali insuficienca nadledvične skorje), - sočasno zdravljenje z določenimi drugimi zdravili.
In healthy subjects and diabetic patients, insulin serum concentrations indicated a slower and much more prolonged absorption and showed a lack of a peak after subcutaneous injection of insulin glargine in comparison to human NPH insulin. 
Absorpcija Koncentracija insulina v serumu pri zdravih preiskovancih in diabetikih je po subkutani injekciji insulina glargin v primerjavi s humanim insulinom NPH pokazala počasnejšo in mnogo dolgotrajnejšo absorpcijo ter ni imela vrha.
Priming your pen Prime before each injection. 
Aktivacija peresnika Aktivirajte peresnik pred vsakim injiciranjem.
These include patients: - in whom glycaemic control is markedly improved, - in whom hypoglycaemia develops gradually, - who are elderly, - after transfer from animal insulin to human insulin, - in whom an autonomic neuropathy is present, - with a long history of diabetes, - suffering from a psychiatric illness, - receiving concurrent treatment with certain other medicinal products (see section 4.5). 
- ki so starejši, - po prehodu z živalskega na humani insulin, - ki imajo avtonomno nevropatijo, - z dolgo anamnezo diabetesa,
Step 13: 
Korak 13:
Children below 2 years of age The safety and efficacy of insulin glargine have not been established No data are available. 
Varnost in učinkovitost insulina glargin nista bili ugotovljeni.
You will NOT receive your insulin by turning the dose knob. 
Z obračanjem gumba za odmerjanje NE prejmete insulina.
IGF-1 receptor binding: The affinity of insulin glargine for the human IGF-1 receptor is approximately 5 to 8-fold greater than that of human insulin (but approximately 70 to 80-fold lower than the one of IGF-1), whereas M1 and M2 bind the IGF-1 receptor with slightly lower affinity compared to human insulin. 
8-krat večja kot afiniteta humanega insulina (vendar približno 70- do 80-krat manjša kot afiniteta IGF
There is no experience with the use of ABASAGLAR in children below the age of 2 years. 
Pri otrocih, mlajših od 2 let, izkušenj z uporabo zdravila ABASAGLAR ni.
ABASAGLAR 100 units/mL injection KwikPen insulin glargine 
ABASAGLAR 100 enot/ml injekcija KwikPen insulin glargin subkutana uporaba
Talk to your doctor, pharmacist or nurse before using ABASAGLAR. 
Posvetujte se z zdravnikom ali s farmacevtom, preden vzamete katero koli zdravilo.
- you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to ABASAGLAR, hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night), - your blood sugar levels are almost normal or are unstable, - you change the area of skin where you inject insulin (for example from the thigh to the upper arm), - you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism. 
verjetnejša zjutraj kot ponoči), - je koncentracija vašega krvnega sladkorja skoraj normalna ali ni stabilna, - zamenjate predel kože, kamor injicirate insulin (na primer s stegna na nadlaket), - imate hudo bolezen ledvic ali jeter ali kakšno drugo bolezen, kot je nezadostno delovanje ščitnice.
ABASAGLAR contains insulin glargine. 
Zdravilo ABASAGLAR vsebuje insulin glargin.
• Eye reactions 
• Splošne težave
Medicinal product subject to medical prescription 
Imetnik dovoljenja za promet z zdravilom
Common Uncommon Rare Very rare 
Zelo pogosti Pogosti
Keep the cartridge in the outer carton in order to protect from light. 
Vložek shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.